Ureteral Stent

DEVICE7 trials

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Emory University, University of British Columbia, Assiut University, University of Chicago

Conditions

CancerHydronephrosisKidney StonesMalignancyManagement of Obstructed Infected KidneyObservationPyelonephritis AcuteRenal Calculi

Early Phase 1

Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent

WithdrawnNCT05640115

University of ChicagoCancer, Malignancy, Ureter Injury +3

Start: 2023-09-22End: 2024-08-21Updated: 2024-12-19

Phase 2

Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation

CompletedNCT00250406

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sRenal Calculi, Ureteral Obstruction

Start: 2005-11-30End: 2009-03-31Updated: 2013-12-20

Unknown Phase

Ureteral Stent Length and Patient Symptoms

TerminatedNCT00288457

Emory UniversityKidney Stones

Start: 2006-02-28End: 2006-10-31Updated: 2013-12-24

The Impact of Ureteral Stents on Peristalsis

WithdrawnNCT01739738

University of British ColumbiaHydronephrosis, Kidney Stones, Tumor

Start: 2012-12-31End: 2014-12-31Updated: 2020-03-25

Ureteral Stent Versus Percutaneous Nephrostomy in Acutely Obstructed Infected Kidney

CompletedNCT03498794

Assiut UniversityManagement of Obstructed Infected Kidney

Start: 2019-03-05End: 2020-04-01Updated: 2020-05-11

Optimal Stent Duration After Ureteroscopy

Active, not recruitingNCT06045962

Mayo ClinicUreteral Stent

Start: 2023-11-01End: 2027-01-01Target: 172Updated: 2026-09-17

Real-World Study of Obstructive Upper Urinary Tract Stones and Acute Pyelonephritis

Not yet recruitingNCT07816991

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineObservation, Pyelonephritis Acute, Strategy Training +1

Start: 2026-10-01End: 2029-11-01Target: 1650Updated: 2026-09-14